LUNG ADENOCARCINOMA
Clinical trials for LUNG ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LUNG ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily pill keep lung spots from turning into cancer?
Disease control Recruiting nowThis study tests whether the drug osimertinib can stop or shrink small, hazy lung spots (called GGNs) that remain after surgery for a type of lung cancer. About 59 adults with EGFR-mutated lung cancer will take a daily pill for a period of time. The goal is to see if the drug pre…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 26, 2026 04:08 UTC
-
Could a diabetes pill help fight lung cancer? new study begins
Disease control Recruiting nowThis early study tests whether dapagliflozin, a drug approved for diabetes and heart failure, is safe and tolerable when given before surgery to people with stage IA lung adenocarcinoma. About 48 participants will take the drug for a short time before their planned surgery. The g…
Matched conditions: LUNG ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Freezing tumors may boost lung cancer treatment, new trial hopes
Disease control Recruiting nowThis study tests if adding a freezing procedure called cryoablation to standard immunotherapy and chemotherapy helps people with advanced lung cancer live longer. About 214 adults with metastatic lung adenocarcinoma will be split into two groups: one gets the freezing treatment p…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Last hope? new combo therapy targets bulky lung tumors
Disease control Recruiting nowThis study tests a new treatment for people with advanced lung cancer that cannot be removed by surgery and has stopped responding to standard therapies. The approach combines a special type of radiation that targets only the center of the tumor with an immunotherapy drug that wa…
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Karl Landsteiner University of Health Sciences • Aim: Disease control
Last updated May 26, 2026 04:01 UTC
-
Ohio study aims to beat stage IV lung cancer with smarter drugs
Disease control Recruiting nowThis study looks at whether a special care plan called the Beating Lung Cancer in Ohio protocol can help people with stage IV non-small cell lung cancer live longer and feel better. It compares using targeted therapies and immunotherapies (which have fewer side effects than chemo…
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:00 UTC
-
New combo targets Hard-to-Treat cancers with STK11 mutation
Disease control Recruiting nowThis study tests a new drug called TNG260 combined with an immunotherapy (pembrolizumab) in people with advanced solid tumors that have a specific gene change (STK11 mutation). The goal is to find the safest dose and see if the combination can shrink tumors. About 126 adults with…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New combo therapy aims to shrink brain tumors while saving memory
Disease control Recruiting nowThis study tests two ways to treat lung cancer that has spread to the brain. One group gets focused radiation plus a drug called bevacizumab; the other gets whole-brain radiation that tries to protect the memory center. The goal is to see which approach better controls the brain …
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New drug combo shows promise for tough cancers
Disease control Recruiting nowThis study tests an experimental drug called AZD5335, alone or with other cancer treatments, in people with advanced ovarian, lung, or endometrial cancer. The goal is to see if it is safe and can shrink tumors. About 506 participants will take part in this early-phase trial.
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment for people with advanced melanoma or other solid tumors that have spread. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The goal is to find a safe dose and see if t…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New drug combo aims to shrink lung tumors and extend survival
Disease control Recruiting nowThis study tests whether adding an experimental drug called TRC102 to standard treatment (chemotherapy, radiation, and immunotherapy) can better shrink tumors and extend life in people with stage III non-squamous lung cancer. TRC102 blocks cancer cells from repairing damage, maki…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Less lung removal may be just as good for small cancers
Disease control Recruiting nowThis study compares two types of lung surgery for people with small lung cancers (≤2 cm). One surgery removes only a part of the lung lobe (segmentectomy), while the other removes the entire lobe (lobectomy). The goal is to see if the smaller surgery works just as well at prevent…
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Keto diet before PET scan may spot hidden lung cancer
Diagnosis Recruiting nowThis study tests whether eating a special low-glucose, high-fat diet for 7 days before a PET scan can help doctors see a type of slow-growing lung cancer that often gets missed on standard scans. About 30 adults with suspected or confirmed lepidic-predominant lung adenocarcinoma …
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Diagnosis
Last updated May 26, 2026 04:02 UTC
-
New PET tracer could spot lung cancer sooner
Diagnosis Recruiting nowThis study tests a new PET scan tracer called Me-4FDG to see if it can find lung cancer earlier and more accurately. About 60 adults with lung nodules will get the tracer and a PET scan. The goal is to improve early diagnosis and reduce unnecessary procedures.
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 13:55 UTC
-
Yoga and mindfulness may boost health in cancer survivors
Symptom relief Recruiting nowThis study looks at whether yoga and mindfulness can improve the emotional, social, and physical well-being of people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. Researchers will also check if these practices affect inflammation and gene activity. About 100 a…
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated May 26, 2026 03:54 UTC
-
New study aims to boost quality of life for veterans battling lung cancer
Symptom relief Recruiting nowThis study looks at whether giving veterans with lung cancer extra support can help them feel better day-to-day. About 194 veterans will take part, and researchers will track their quality of life using surveys. The goal is to see if simple added help can make a real difference.
Matched conditions: LUNG ADENOCARCINOMA
Phase: NA • Sponsor: Palo Alto Veterans Institute for Research • Aim: Symptom relief
Last updated May 26, 2026 03:54 UTC
-
Mexican lung cancer study seeks hidden genetic clues
Knowledge-focused Recruiting nowThis observational study aims to find how common inherited gene changes are in Mexican patients with a type of lung cancer called adenocarcinoma. Researchers will collect blood samples from 332 participants to look for these genetic variants and see how they relate to patient out…
Matched conditions: LUNG ADENOCARCINOMA
Sponsor: Oscar Gerardo Arrieta Rodríguez • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
New lung cancer clues found in chest fluid?
Knowledge-focused Recruiting nowThis study looks at fluid from around the lungs (pleural effusion) to find new markers that could help diagnose lung adenocarcinoma. Researchers will compare samples from 100 patients with and without cancer. The goal is to see if these markers can make diagnosis easier and more …
Matched conditions: LUNG ADENOCARCINOMA
Sponsor: Fu Jen Catholic University • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC
-
New tool aims to take guesswork out of lung cancer testing decisions
Knowledge-focused Recruiting nowThis study aims to create a decision aid for people with a type of lung cancer (lung adenocarcinoma) who have just had surgery. The tool will help patients and their doctors work together to decide whether to do molecular testing on the tumor. About 190 people, including patients…
Matched conditions: LUNG ADENOCARCINOMA
Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Knowledge-focused
Last updated May 18, 2026 11:58 UTC